Skip to Main Content

Author Details

Steven M Dubinett
David Geffen School of Medicine at university of california los angeles
1987
272
68
PMIDPaper TitleJournal TitlePublished Year
36778362Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma.bioRxiv2023
37674811Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.JTO Clin Res Rep2023
37830618Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment.Cells2023
37730274CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.J Immunother Cancer2023
37477508Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma.Cancer Res2023
36778362Glucose deprivation promotes pseudo-hypoxia and de-differentiation in lung adenocarcinoma.bioRxiv2023
37399400Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.Proc Natl Acad Sci U S A2023
37069149Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.Signal Transduct Target Ther2023
36922590Spatial mapping of mitochondrial networks and bioenergetics in lung cancer.Nature2023
37830618Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment.Cells2023
37730274CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.J Immunother Cancer2023
37674811Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.JTO Clin Res Rep2023
37399400Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.Proc Natl Acad Sci U S A2023
37069149Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma.Signal Transduct Target Ther2023
37477508Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma.Cancer Res2023
36922590Spatial mapping of mitochondrial networks and bioenergetics in lung cancer.Nature2023
35149536cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution.Clin Cancer Res2022
36175411Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer.Nat Commun2022
36098652The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.Cancer Discov2022
35640927Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.J Immunother Cancer2022
35501466Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature.Commun Biol2022
35851153Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer.Semin Oncol2022
35149536cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution.Clin Cancer Res2022
35501466Statistical parametrization of cell cytoskeleton reveals lung cancer cytoskeletal phenotype with partial EMT signature.Commun Biol2022
35640927Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.J Immunother Cancer2022
35851153Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer.Semin Oncol2022
36175411Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer.Nat Commun2022
36098652The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma.Cancer Discov2022
33318037Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity.Cancer Discov2021
33972311Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing.Cancer Discov2021
33809063Single-Cell Expression Landscape of SARS-CoV-2 Receptor <i>ACE2</i> and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.Cancers (Basel)2021
34234141Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis.Nat Commun2021
33853830Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer.Cancer Res2021
33952700Immune evasion in HPV<sup>-</sup> head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.Proc Natl Acad Sci U S A2021
34001525Early Diagnosis and Screening for Lung Cancer.Cold Spring Harb Perspect Med2021
34298808Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer.Cancers (Basel)2021
33318037Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity.Cancer Discov2021
34591103COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California.JAMA Netw Open2021
34590007Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC.JTO Clin Res Rep2021
34755131Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.Cell Rep Med2021
34806054Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC.JTO Clin Res Rep2021
33853830Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer.Cancer Res2021
33809063Single-Cell Expression Landscape of SARS-CoV-2 Receptor <i>ACE2</i> and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients.Cancers (Basel)2021
34591103COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California.JAMA Netw Open2021
34590007Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC.JTO Clin Res Rep2021
34755131Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.Cell Rep Med2021
34806054Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC.JTO Clin Res Rep2021
34298808Genotoxic Treatment Enhances Immune Response in a Genetic Model of Lung Cancer.Cancers (Basel)2021
34234141Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis.Nat Commun2021
33952700Immune evasion in HPV<sup>-</sup> head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.Proc Natl Acad Sci U S A2021
  • 1 - 50 of 544

Recommended Authors

Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 1
Kien Pham
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Mary Zhang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 0
Fei Li
Shanghai Pulmonary Hospital, Tongji University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Chad V Pecot
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 5
Xi Liu
College of Biology and Food, Shangqiu Normal University
Career Start Year 2007
Number of shared co-authors 8
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 13
Julie A Hong
National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 0
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Paola Cappello
University of Turin
Career Start Year 1998
Number of shared co-authors 0
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
Roya Navab
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 0
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1996
Number of shared co-authors 2
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year 1996
Number of shared co-authors 1
Ping Yang
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 6
Sichuan Xi
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 2
Michael Peyton
Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center
Career Start Year 1994
Number of shared co-authors 11
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 3
David N Watkins
Research Institute in Oncology and Hematology
Career Start Year 1991
Number of shared co-authors 2
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Rosalba Salcedo
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 1
David S Schrump
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 1
Fredika M Robertson
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 7
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 10
David M Jablons
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1981
Number of shared co-authors 4
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 15

Collaborators

Kostyantyn Krysan
David Geffen School of Medicine at University of California at Los Angeles
Co-authored papers 49
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 32
Edward B Garon
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 27
Avrum Spira
Boston University School of Medicine
Co-authored papers 22
Michael C Fishbein
Co-authored papers 21
Maie A St John
Co-authored papers 20
Lee Goodglick
Co-authored papers 12
Jane Yanagawa
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers 12
John D Minna
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 11
Marc E Lenburg
Co-authored papers 10
Denise R Aberle
David Geffen School of Medicine at university of california los angeles
Co-authored papers 8
Tristan Grogan
University of California Los Angeles
Co-authored papers 7
Clara E Magyar
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 6
Heather R Christofk
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 6
Yonggang Zhou
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 5
Wenyuan Li
Harvard Medical School
Co-authored papers 5
Zorawar S Noor
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Xianghong Jasmine Zhou
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 5
Jianjun Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Dennis J Slamon
David Geffen School of Medicine at university of california los angeles
Co-authored papers 4
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Co-authored papers 4
Aaron Lisberg
Jonsson Comprehensive Cancer Center, university of california los angeles
Co-authored papers 4
Eileen Fung
Co-authored papers 4
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
Pierre P Massion
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 3
Robert B Cameron
University of California los angeles
Co-authored papers 3
Roy S Herbst
Yale School of Medicine
Co-authored papers 3
Joshua D Campbell
Co-authored papers 3
Carol M Mangione
Fielding School of Public Health, University of California los angeles
Co-authored papers 3
Nicholas Jackson
University of California los angeles
Co-authored papers 3
Release 1.2